COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.The application to the U.S.
Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns.Pfizer Chief Executive Officer Albert Bourla confirmed the application had been made in a video posted on the company's website on Friday afternoon.The FDA said on Friday it would hold a meeting of the advisory committee on Dec.
10 at which members would discuss the vaccine. The agency declined to predict how long its review would take, although both Pfizer and U.S.